Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Jeong, Seri ^a   Park, Seho ^a   Park, Byeong Woo ^a   Park, Younhee ^b   Kwon, Oh Joong ^c   Kim, Hyon Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA G ANTIGEN; PRIMER DNA;

3' UNTRANSLATED REGION; ALLELE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREAST CARCINOGENESIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK REDUCTION; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; STATISTICAL MODEL; TUMOR ESCAPE;

AREA UNDER CURVE; BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-G ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; TUMOR ESCAPE;

EID: 84901593851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098284     Document Type: Article

References (35)

1. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, et al. (2009) Early breast cancer. Lancet 373: 1463-1479.
2. Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, et al. (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6: 391-401. (Pubitemid 43078894)
3. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, et al. (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784-1792. (Pubitemid 41549890)
4. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N (2008) HLA-G: from biology to clinical benefits. Trends Immunol 29: 125-132.
5. Yan WH (2011) Human leukocyte antigen-G in cancer: are they clinically relevant? Cancer Lett 311: 123-130.
6. Park GM, Lee S, Park B, Kim E, Shin J, et al. (2004) Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 313: 606-611. (Pubitemid 38021873)
7. Provatopoulou X, Kalogera E, Sagkriotis A, Zagouri F, Nonni A, et al. (2012) Soluble human leukocyte antigen-g expression in patients with ductal and lobular breast malignancy. Anticancer Res 32: 1021-1026.
8. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, et al. (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186: 1809-1818. (Pubitemid 27524591)
9. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, et al. (1999) HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11: 1351-1356. (Pubitemid 29355674)
10. Rajagopalan S, Long EO (1999) A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189: 1093-1100.
11. Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, et al. (2003) Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33: 125-134. (Pubitemid 36157650)
12. Rahimi R, Hosseini AZ, Yari F (2010) The polymorphism of human leucocyte antigen-G gene in a healthy population of Iran. Int J Immunogenet 37: 269-272.
13. Lin A, Yan WH, Xu HH, Tang LJ, Chen XF, et al. (2007) 14 bp deletion polymorphism in the HLA-G gene is a risk factor for idiopathic dilated cardiomyopathy in a Chinese Han population. Tissue Antigens 70: 427-431. (Pubitemid 47537405)
14. Castelli EC, Mendes-Junior CT, Donadi EA (2007) HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population. Tissue Antigens 70: 62-68. (Pubitemid 46890284)
15. Matte C, Lacaille J, Zijenah L, Ward B, Roger M (2000) HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. Hum Immunol 61: 1150-1156. (Pubitemid 32043893)
16. van der Ven K, Skrablin S, Engels G, Krebs D (1998) HLA-G polymorphisms and allele frequencies in Caucasians. Hum Immunol 59: 302-312. (Pubitemid 28225989)
17. Hviid TV (2006) HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update 12: 209-232.
18. Chen Y, Gao XJ, Deng YC, Zhang HX (2012) Relationship between HLA-G gene polymorphism and the susceptibility of esophageal cancer in Kazakh and Han nationality in Xinjiang. Biomarkers 17: 9-15.
19. Lau DT, Norris MD, Marshall GM, Haber M, Ashton LJ (2011) HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma. Tissue Antigens 78: 421-427.
20. Jiang Y, Chen S, Jia S, Zhu Z, Gao X, et al. (2011) Association of HLA-G 39 UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population. DNA Cell Biol 30: 1027-1032.
21. Ferguson R, Ramanakumar AV, Koushik A, Coutlee F, Franco E, et al. (2011) Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. Int J Cancer.
22. Castelli EC, Mendes-Junior CT, Viana de Camargo JL, Donadi EA (2008) HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens 72: 149-157. (Pubitemid 352009823)
23. Rebmann V, Busemann A, Lindemann M, Grosse-Wilde H (2003) Detection of HLA-G5 secreting cells. Hum Immunol 64: 1017-1024. (Pubitemid 37413709)
24. Zheng N, Wang CX, Zhang X, Du LT, Zhang J, et al. (2011) Up-regulation of HLA-G expression in cervical premalignant and malignant lesions. Tissue Antigens 77: 218-224.
25. Cao M, Yie SM, Liu J, Ye SR, Xia D, et al. (2011) Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens 78: 120-128.
26. He X, Dong DD, Yie SM, Yang H, Cao M, et al. (2010) HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Ann Surg Oncol 17: 1459-1469.
27. Chen HX, Lin A, Shen CJ, Zhen R, Chen BG, et al. (2010) Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer. Hum Immunol 71: 892-898.
28. Elliott RL, Jiang XP, Phillips JT, Barnett BG, Head JF (2011) Human leukocyte antigen G expression in breast cancer: role in immunosuppression. Cancer Biother Radiopharm 26: 153-157.
29. Hviid TV, Hylenius S, Rorbye C, Nielsen LG (2003) HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55: 63-79. (Pubitemid 36702743)
30. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, et al. (2003) The 14 bp deletion-insertion polymorphism in the 39 UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 64: 1005-1010. (Pubitemid 37413707)
31. Gaddy VT, Barrett JT, Delk JN, Kallab AM, Porter AG, et al. (2004) Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells. Clin Cancer Res 10: 5215-5225. (Pubitemid 39099796)
32. de Kruijf EM, Sajet A, van Nes JG, Natanov R, Putter H, et al. (2010) HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol 185: 7452-7459.
33. Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102: 170-178.
34. Sayed D, Badr G, Maximous D, Mikhail NN, Abu-Tarboush F, et al. (2010) HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients. Tissue Antigens 75: 40-47.
35. Barrier BF, Kendall BS, Sharpe-Timms KL, Kost ER (2006) Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol 103: 25-30. (Pubitemid 44389864)